Drug intelligence / Profile preview

lingo-1-Fc

Development stage
Unknown
Modality
Fc-Fusion Proteins → Carrier/Scaffold Proteins → Recombinant Proteins and Enzymes
Administration
Intravenous
01

Overview

LINGO-1-Fc is a recombinant fusion protein designed as an **antagonist** of LINGO-1 signaling pathways in the central nervous system. It acts by blocking LINGO-1’s interaction with receptor complexes that inhibit axonal outgrowth and myelination, specifically the NgR1/p75/LINGO-1 complex. LINGO-1-Fc promotes axonal sprouting, reduces RhoA activation, increases oligodendrocyte and neuronal survival, and facilitates functional recovery after neural injury. In preclinical models, LINGO-1-Fc has been shown to improve remyelination, neurobehavioral deficits, and neuron survival after spinal cord injury and Parkinson’s disease-related damage. The mechanism involves antagonism of LINGO-1-mediated inhibition of EGFR/Akt signaling and modulation of CNS remyelination pathways[1][5].

Other names
LINGO-1 antagonistLINGO1 antagonistLINGO 1 antagonistsoluble LINGO-1-FcLINGO-1 blocking fusion proteinLINGO1 blocking fusion proteinLINGO 1 blocking fusion protein
02

Targets

EGFR (Epidermal growth factor receptor)RHOA (Ras homolog gene family member A)LINGO1 (Leucine-rich repeat and immunoglobulin-like domain-containing Nogo receptor-interacting protein 1)

Beyond the preview

Go deeper on lingo-1-Fc.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on lingo-1-Fc.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call